Yadav Sapkota, PhD, and Yutaka Yasui, PhD, Epidemiology and Cancer Control Department; and Melissa Hudson, MD, Cancer Control and Survivorship Program.
Researchers at St. Jude Children’s Research Hospital combined genetic and clinical risk factors to create a method to predict which childhood cancer patients are most likely to develop severe or “morbid” obesity as adults. The tool will give physicians and survivors the information to help motivate positive lifestyle changes. The research was published today in Nature Medicine.
Childhood cancer survivors are at a high risk of developing many chronic illnesses. Of particular concern are conditions that can affect the heart, because certain cancer therapies can cause long-term cardiac damage. Adult survivors of childhood cancer have high rates of obesity, which is a major risk factor for cardiac disease.
St. Jude scientists developed a method to predict, at diagnosis, which children with cancer are at the highest risk of developing severe obesity as adults. Using the tool, researchers calculated that survivors with the highest genetic risk score were at 53 times greater risk of obesity compared to survivors with the lowest genetic risk score. The risk of obesity was independent of other general risk factors. The National Institutes of Health defines severe or “morbid” obesity as having a body mass of 40 kg/m2 or higher.
The St. Jude method provides an opportunity for targeted interventions for children and their families to adopt healthy lifestyles early in life to prevent obesity in adulthood. This research is one of the first studies to show the contribution of genetics and treatment-related risk factors to increased risk of developing obesity and related traits that survivors experience compared to the general population.
“It is important for childhood cancer survivors to know if they are at risk for developing various chronic conditions,” said first and co-corresponding author Yadav Sapkota, Ph.D., St. Jude Department of Epidemiology and Cancer Control. “We have developed a prediction model that can help healthcare providers identify which survivors are likely to develop severe obesity.”
“In the future as this type of genetic testing becomes more clinically available, this knowledge will provide clinicians with the opportunity to intensify efforts to promote healthy weight maintenance in survivors at high risk for severe obesity,” said Melissa Hudson, M.D., co-author and co-leader of the St. Jude Cancer Control and Survivorship Program. “Good nutrition and regular physical activity are important for all cancer patients but are particularly important for those with genetic and treatment risks associated with obesity,” she said.
Obesity risk scores
The obesity risk score is based on clinical, lifestyle and genetic factors. It can be calculated when the patient is diagnosed with childhood cancer.
The scientists applied their genetic risk models to more than 4,000 St. Jude childhood cancer survivors enrolled in the St. Jude Lifetime Cohort Study (St. Jude LIFE). Participants have had whole genome sequencing of their germline (inherited) DNA. St. Jude LIFE participants return to St. Jude throughout their adult lives for regular health screenings.
Researchers checked to see how their tool performed in the survivor health data, predicting adult obesity in St. Jude LIFE childhood cancer survivors of European ancestry. The genetic risk score is an aggregate score derived from approximately 2.1 million common genetic variants associated with body mass index developed in individuals of European ancestry in the general population.
When investigators applied the same method to a different cohort of adult survivors of childhood cancer, they found a slightly weaker signal, but the score still predicted severe obesity. The Childhood Cancer Survivor Study (CCSS) provided the second cohort of 6,064 survivors. CCSS is a retrospective analysis of cancer survivors at least five years post-therapy treated at one of 31 institutions in the U.S. and Canada.
“This is a really important advance for the care of survivors,” said co-corresponding author Yutaka Yasui, Ph.D., St. Jude Department of Epidemiology and Cancer Control. “We can identify the highest risk survivors with this method – a genetic method. We can know which childhood cancer patients are high risk for severe or other obesity early on in life, so we can give personalized advice to them.”
An ancestry problem
While the findings hold tremendous value for childhood cancer survivors of European ancestry, the genetic risk score was not predictive of obesity in people of African ancestry in either cohort. The researchers addressed this by developing a different genetic risk score customized for people of African ancestry.
“Populations of non-European ancestry are understudied,” Sapkota said. “That's why genomic studies often don’t apply directly to them. The number of genetic studies of African ancestry and obesity is very small, but we still explored them to create a separate, ancestry-specific risk score. When we did that, we were able to predict obesity with statistical significance in survivors of African ancestry. That means, to better predict a risk of a given disease by using genetic variables, we need to consider the findings from within shared ancestries.”
The St. Jude LIFE cohort data are freely available to other scientists on the St. Jude Cloud.
Authors and funding
The study’s other authors are Stephanie Dixon, Carmen Wilson, Zhaoming Wang, Jinghui Zhang, Gregory Armstrong, Leslie Robison and Angela Delaney, of St. Jude; Weiyu Qiu, University of Alberta; Wendy Leisenring and Eric Chow, Fred Hutchinson Cancer Research Center; and Smita Bhatia, University of Alabama.
The study was supported by grants from by the National Cancer Institute (CA21765, R01CA261898, R01CA216354) and ALSAC, the fundraising and awareness organization of St. Jude.
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease, and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit stjude.org, read St. Jude Progress, a digital magazine, and follow St. Jude on social media at @stjuderesearch.